Literature DB >> 18299856

[Burden of illness. First routine report on socio-medical consequences of inflammatory rheumatic disease in Germany].

W Mau1, W Beyer, I Ehlebracht-König, M Engel, E Genth, B Greitemann, W H Jäckel, A Zink.   

Abstract

A synopsis of different socio-medical consequences of inflammatory rheumatic diseases is not yet available for Germany. Therefore, the data reported during the past decade for rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, systemic sclerosis, systemic lupus erythematodes, and Wegener's granulomatosis are summarized in this article. Apart from clinical studies, relevant data sources were the national data base of the German collaborative arthritis centres, statistical figures from the compulsory health insurance and the national pension insurance scheme. Data were mainly available for sick leave and work disability showing limitations, which frequently occurred during the early course of diseases and increased with disease duration. Furthermore, different risk factors were identified. Measures to maintain continued participation in the labour force, such as part-time employment, partial work disability instead of full work disability, were not being adequately utilized. Only few data regarding the need of help and care were available. The proportion of patients in need of help and care increased with the duration of rheumatoid arthritis to more than 50% after more than 2 decades. This review presents detailed information concerning aspects of the burden of rheumatic diseases, which are frequently not adequately taken into account. They may be useful for the advice and care of individual patients as well as for decision processes concerning the health care system.

Entities:  

Mesh:

Year:  2008        PMID: 18299856     DOI: 10.1007/s00393-007-0250-9

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  16 in total

1.  Loss of physical independence in rheumatoid arthritis: interview data from a representative sample of patients in rheumatologic care.

Authors:  G Westhoff; J Listing; A Zink
Journal:  Arthritis Care Res       Date:  2000-02

2.  Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis.

Authors:  Angela Zink; Katja Thiele; Doerte Huscher; Joachim Listing; Joachim Sieper; Andreas Krause; Erika Gromnica-Ihle; Ulrich von Hinueber; Siegfried Wassenberg; Ekkehard Genth; Matthias Schneider
Journal:  J Rheumatol       Date:  2006-01       Impact factor: 4.666

3.  [Work disability work in the first year of chronic polyarthritis. A comparison with members of the legal health health insurance].

Authors:  W Mau; M Bornmann; H Weber
Journal:  Z Rheumatol       Date:  1997 Jan-Feb       Impact factor: 1.372

4.  [Lupus in Germany: analysis within the German lupus self-help organization (LULA)].

Authors:  R Fischer-Betz; E Wessel; J Richter; B Winkler-Rohlfing; R Willers; M Schneider
Journal:  Z Rheumatol       Date:  2005-03       Impact factor: 1.372

5.  [Long-term follow-up and prognosis of work capacity in the early stage of chronic polyarthritis].

Authors:  W Bräuer; S Merkesdal; W Mau
Journal:  Z Rheumatol       Date:  2002-08       Impact factor: 1.372

6.  Prediction of permanent work disability in a follow-up study of early rheumatoid arthritis: results of a tree structured analysis using RECPAM.

Authors:  W Mau; M Bornmann; H Weber; H F Weidemann; H Hecker; H H Raspe
Journal:  Br J Rheumatol       Date:  1996-07

7.  Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries.

Authors:  A Boonen; D van der Heijde; R Landewé; A Spoorenberg; H Schouten; M Rutten-van Mölken; F Guillemin; M Dougados; H Mielants; K de Vlam; H van der Tempel; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2002-05       Impact factor: 19.103

8.  Work disability in early rheumatoid arthritis: higher rates but better clinical status in Finland compared with the US.

Authors:  C P Chung; T Sokka; P G Arbogast; T Pincus
Journal:  Ann Rheum Dis       Date:  2006-06-01       Impact factor: 19.103

9.  Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources.

Authors:  J Ruof; J L Hülsemann; T Mittendorf; S Handelmann; J M von der Schulenburg; H Zeidler; S Merkesdal
Journal:  Ann Rheum Dis       Date:  2003-06       Impact factor: 19.103

10.  Effect of Wegener's granulomatosis on work disability, need for medical care, and quality of life in patients younger than 40 years at diagnosis.

Authors:  Eva Reinhold-Keller; Karen Herlyn; Rosemarie Wagner-Bastmeyer; Joachim Gutfleisch; Hartmut H Peter; Heiner H Raspe; Wolfgang L Gross
Journal:  Arthritis Rheum       Date:  2002-06-15
View more
  11 in total

1.  [News from the rehabilitation field].

Authors:  W Mau; E Genth; G Stucki
Journal:  Z Rheumatol       Date:  2008-11       Impact factor: 1.372

2.  [Trends of work force participation of patients with rheumatic diseases : results from German social insurance data and the national database of the German collaborative arthritis centers].

Authors:  W Mau; K Thiele; J Lamprecht
Journal:  Z Rheumatol       Date:  2014-02       Impact factor: 1.372

3.  [Preservation of ability to work and securing vocational participation : non-pharmaceutical support options for rheumatologists].

Authors:  Y Drambyan; K Parthier
Journal:  Z Rheumatol       Date:  2014-02       Impact factor: 1.372

Review 4.  [Long-term trends in rheumatology care : Achievements and deficits in 25 years of the German national rheumatology database].

Authors:  K Albrecht; J Callhoff; A Zink
Journal:  Z Rheumatol       Date:  2019-10       Impact factor: 1.372

5.  Reduction in sickness absence in patients with rheumatoid arthritis receiving adalimumab: data from a German noninterventional study.

Authors:  Klaus Krüger; Jürgen Wollenhaupt; Hanns-Martin Lorenz; Ekkehard Röther; Bianca M Wittig
Journal:  Rheumatol Int       Date:  2011-12-30       Impact factor: 2.631

6.  [Fertility preservation for young patients with autoimmune diseases and the need for cytotoxic treatment. Clinical experiences from interdisciplinary consultation].

Authors:  M Henes; J C Henes; M Schmalzing; E Neunhoeffer; R Rothmund; I Kötter; B Lawrenz
Journal:  Z Rheumatol       Date:  2011-02       Impact factor: 1.372

7.  [Social participation and activities of daily living of patients with inflammatory rheumatic diseases : support by self-help, exercise therapy and new media].

Authors:  K Mattukat; A Thyrolf
Journal:  Z Rheumatol       Date:  2014-02       Impact factor: 1.372

8.  [Rheumatoid arthritis today].

Authors:  N Leuchten; M Aringer
Journal:  Internist (Berl)       Date:  2008-12       Impact factor: 0.743

9.  [Rehabilitation and outpatient physiotherapy in rheumatic disease patients. Results of cross-sectional studies of patients with rheumatoid arthritis or ankylosing spondylitis and rheumatologists].

Authors:  W Mau; A Müller
Journal:  Z Rheumatol       Date:  2008-11       Impact factor: 1.372

10.  [Rheumatological rehabilitation today. Exemplified by two case reports].

Authors:  I Ehlebracht-König; W Mau
Journal:  Z Rheumatol       Date:  2008-11       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.